Cardiovascular and Cerebrovascular Safety of Ranibizumab, Bevacizumab, and Aflibercept in Ocular Diseases: an Analysis of the FDA Adverse Event Reporting System database (FAERS).
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2244
Abstract: The cardiovascular and cerebrovascular safety of ranibizumab, bevacizumab, and aflibercept for ocular diseases is unclear. This study aimed to evaluate and compare the cardiovascular and cerebrovascular safety in patients receiving ranibizumab, bevacizumab, and aflibercept for… read more here.
Keywords: ranibizumab bevacizumab; cardiovascular cerebrovascular; bevacizumab aflibercept; bevacizumab ... See more keywords
Comparative Retinal Vessel Size Study of Intravitreal Ranibizumab and Bevacizumab in Eyes with Neovascular Age-Related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000477180
Abstract: Purpose: The aim of this paper was to assess and compare the effects of intravitreal ranibizumab and bevacizumab on retinal vessel diameter in eyes with neovascular age-related macular degeneration (AMD). Methods: Patients with neovascular AMD… read more here.
Keywords: eyes neovascular; retinal vessel; ranibizumab bevacizumab; intravitreal ranibizumab ... See more keywords
Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment*
Sign Up to like & getrecommendations! Published in 2017 at "Seminars in Ophthalmology"
DOI: 10.3109/08820538.2015.1072222
Abstract: Abstract Objective: To describe visual and anatomical outcomes following bi-weekly intravitreal ranibizumab/bevacizumab injections in eyes with refractory neovascular age-related macular degeneration (AMD) and pigment epithelial detachment (PED). Design: Retrospective, consecutive, interventional case series. Participants: Eighteen… read more here.
Keywords: weekly intravitreal; refractory neovascular; bevacizumab; ranibizumab bevacizumab ... See more keywords
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14020265
Abstract: Background: A drug and disease assessment model was used to evaluate the impact of different treatment regimens on intravitreal ranibizumab, bevacizumab, aflibercept, and brolucizumab concentrations and the proportion of free vascular endothelial growth factor (VEGF)… read more here.
Keywords: ranibizumab bevacizumab; proportion; vegf; anti vegf ... See more keywords